Huron Consulting Group Inc. - Common Stock (HURN)

CUSIP: 447462102

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class
Equity / Common Stock
Total 13F shares
17,416,144
Total 13F value
$2,556,495,894
Holder snapshot 6 visible 7 signals
Share change
-193,919
Put/Call ratio
658%
SEC-reported price per share
$146.77
Number of holders
279
Value change
-$23,439,729
Number of buys
119
Open additional details 1 more signal available
Number of sells
182
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,425,455

Security key

447462102

Report period

Q3 2025

Institutions

279

Top holders

10

HURN full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Huron Consulting Group Inc. SEC filings Huron Consulting Group Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of HURN - Huron Consulting Group Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DIMENSIONAL FUND ADVISORS LP
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F Lead comparable stake: 4.1% 13D/G row: DIMENSIONAL FUND ADVISORS LP Showing 1-6 of 15 holder rows.

Quick read

DIMENSIONAL FUND ADVISORS LP leads the comparable SEC ownership view at 4.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DIMENSIONAL FUND ADVISORS LP's linked filing trail.
Comparable ownership Top 5
DIMENSIONAL FUND ADVISORS LP 4.1%
VANGUARD GROUP INC 12%
BlackRock, Inc. 8.2%
UBS AM, a distinct business unit ... 4.9%
Boston Partners 4.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DIMENSIONAL FUND ADVISORS LP
13D/G 13F
Company
13D/G 13F
4.1%
$99,863,907
742,593 shares
 -$26,893,041 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13F
12%
$267,775,250
1,946,890 shares
 — 30 Jun 2025
BlackRock, Inc.
13F
Company
13F
8.2%
$186,144,158
1,353,382 shares
 — 30 Jun 2025
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
13F
4.9%
$111,476,719
810,504 shares
 — 30 Jun 2025
Boston Partners
13F
Company
13F
4.6%
$104,080,923
758,972 shares
 — 30 Jun 2025
FRANKLIN RESOURCES INC
13F
Company
13F
3.7%
$84,024,287
610,908 shares
 — 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
279
Shares
17,416,144
Rows available
279
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
295
Q3 2025 holders
279
Holder diff
-16
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .